反応式
[Cl:1][C:2]1[S:19][C:5]2[NH:6][C:7](=S)[CH2:8][N:9]=[C:10]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=3[Cl:17])[C:4]=2[CH:3]=1.[C:20]([NH:24][NH2:25])(=O)[CH2:21][OH:22]>C(O)CCC>[Cl:1][C:2]1[S:19][C:5]2[N:6]3[C:20]([CH2:21][OH:22])=[N:24][N:25]=[C:7]3[CH2:8][N:9]=[C:10]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=3[Cl:17])[C:4]=2[CH:3]=1参加物
4
実験手順
1.1 g of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-thieno[2,3-e]-1,4-diazepine-2-thione are refluxed for 8 hours with 1.5 g of glycolic acid hydrazide in absolute butanol. The solvent is then distilled off and the residue recrystallized from ethyl acetate containing active carbon to yield 2-chloro-4-(o-chlorophenyl)-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine-9-methanol, melting point 219°-221° C.
後処理
- distillationThe solvent is then distilled off
- customthe residue recrystallized from ethyl acetate containing active carbon
出典と根拠
- ORDレコード
- ord-9309f7b55c5046fc9ce40bf1bacba5b2
- 出典データセット
- uspto-grants-1979_05
- 特許番号
- US04155913
関連ノート
読み込み中…